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Abstract.  Treatment of cells with tumor-promoting 
phorbol diesters, which causes activation of protein 
kinase C, leads to phosphorylation of the epidermal 
growth factor (EGF) receptor at threonine-654.  Addi- 
tion of phorbol diesters to intact cells causes inhibition 
of the EGF-induced tyrosine-protein kinase activity of 
the EGF receptor and it has been suggested that this 
effect of phorbol diesters is mediated by the phos- 
phorylation of the receptor by protein kinase C.  We 
measured the activity of protein kinase C  in A431 
cells by determining the incorporation of [32p]phos- 
phate into peptides containing threonine-654 obtained 
by trypsin digestion of EGF receptors.  After 3 h of 
exposure to serum-free medium,  A431  cells had no 
detectable protein kinase C  activity. Addition of 
EGF to these cells resulted in [32p] incorporation 
into threonine-654 as well as into tyrosine resi- 
dues.  This indicates that EGF promotes the activation 
of protein kinase C  in A431  cells. The phosphor- 
ylation of threonine-654  induced by EGF was 
maximal after only 5 min of EGF addition and the 
[32p] incorporation  into threonine-654 reached 50% of 
the [32p] in a tyrosine-containing peptide.  This indi- 
cates that a  significant percentage of the total EGF 
receptors are phosphorylated by protein kinase C. A 
variety of external  stimuli activate Na÷/H  ÷ exchange, 
including  EGF, phorbol diesters, and hypertonicity.  To 
ascertain whether activation of protein kinase C  is an 
intracellular common effector of all of these systems, 
we measured the activity of protein kinase C  after ex- 
posure of A431  cells to hyperosmotic conditions and 
observed no effect on phosphorylation of threonine- 
654,  therefore,  activation of Na+/H  ÷ exchange by 
hypertonic medium is independent of protein kinase C 
activity.  Since stimulation of protein kinase C  by phor- 
bol diesters results in a decrease in EGF receptor ac- 
tivity, the stimulation of protein kinase C a¢tivity by 
addition of EGF to A431  cells contributes to a feed- 
back mechanism which results in the attenuation of 
EGF receptor function. 
T 
UMOR-PROMOTING phorbol diesters  cause rapid  and 
significant  alterations  of  epidermal  growth  factor 
(EGF) 1 receptor biochemistry in intact  cells.  Within 
minutes  of phorbol 12-myristate  13-acetate (PMA) addition 
to human  epidermoid carcinoma A431 cells (39) or mouse 
fibroblast  Swiss 3T3 cells (4),  the apparent  affinity of the 
EGF  receptor  decreases  and  the  EGF-induced  tyrosine- 
specific protein kinase activity of the cytoplasmic domain of 
the receptor is attenuated  (9,  12). This has been associated 
with rapid phosphorylation of EGF receptors at serine and 
threonine  residues (8, 9, 24). 
Biochemical  investigations  suggest  that  the  Ca  2+-  and 
phospholipid-dependent protein kinase (protein kinase C) is 
the major target for PMA action (for review see reference 33) 
1. Abbreviations  used in this paper: DAG, diacylglycerol; EGF, epidermal 
growth  factor;  PDGF,  platelet-derived  growth  factor;  PI,  phosphatidyl- 
inositol; PMA,  phorbol  12-myristate  13-acetate. 
and constitutes the cellular phorbol diester "receptor" (1, 30, 
32). Since purified protein kinase C phosphorylates the same 
residues of the EGF receptor as are found in PMA-treated 
cells (9), it is likely that protein kinase C catalyzes the phos- 
phorylation  in  both  instances.  Analysis  of tryptic  phos- 
phopeptides from PMA-treated  EGF receptors has revealed 
that a major phosphorylation site is threonine-654  (12, 23), 
which  is  situated  only 9  amino  acids from the predicted 
cytoplasmic face of the plasma membrane.  The phosphoryla- 
tion of threonine-654  may mediate the effects of protein ki- 
nase C on binding  affinity and tyrosine kinase  activity be- 
cause of its location between the extracellular  EGF binding 
domain and the cytoplasmic tyrosine kinase domain. It is not 
known  how  the  binding  domain  communicates  to  the 
cytoplasmic  domain, but since there is a single membrane- 
spanning sequence in the EGF receptor, a site near the inner 
face of the plasma membrane could be a potential  point of 
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PMA to cells blocks the activation of Na+/H  + exchange by 
EGF, platelet-derived growth factor (PDGF), and serum, but 
not by hypertonicity (44, 45).  We postulated that a major 
function of protein kinase C  was to modulate (inhibi0 the 
function of the cell surface receptors for EGF and PDGE If 
protein kinase C  is activated in vivo as a  consequence of 
mitogen addition to ceils, a feedback loop would be estab- 
lished  to  control  the  intracellular  events  associated  with 
mitogen addition to cells. 
Protein kinase C is activated by diacylglycerols (DAGs) in 
vitro (27) which appear to be endogenous analogs of phorbol 
diesters (18). Stimulation of phosphoinositide hydrolysis and 
thus liberation of DAG is believed to be the physiological 
mechanism whereby protein kinase C is activated by mito- 
gens (33). Phosphoinositide turnover has been demonstrated 
to occur in quiescent Swiss 313 cells stimulated with PDGF 
(20) and in A431 cells upon EGF addition (38, 41). The pos- 
sibility exists that protein kinase C  activation in mitogen- 
stimulated cells could be exerting the same influence on mi- 
togen receptors as has been observed in PMA-treated cells. 
Evidence for physiological activation of protein kinase C 
should include not only data on DAG levels but also some 
direct measurement  of phosphate  incorporation resulting 
from protein kinase C action. Because phorbol diesters are 
very poorly metabolized by cells and cause intense,  sus- 
tained stimulation, some estimation of the relative degree of 
phosphorylation which results from a physiological stimulus 
should aid in the ability to judge whether protein kinase C 
can cause negative modulation of mitogen receptors in the 
absence of phorbol diesters. 
We have investigated the consequences of EGF addition to 
human epidermoid carcinoma A431  cells. We have quanti- 
tated the amounts of cellular DAG in the presence or absence 
of EGF and have analyzed the pattern of phosphorylation of 
the EGF receptor caused by PMA or EGE We present evi- 
dence that EGF receptors are phosphorylated at threonine- 
654 as a  result of EGF stimulation presumably as a con- 
sequence  of activation  of protein  kinase  C.  Hypertonic 
solutions,  which  potently  activate  Na+/H  +  exchange  in 
A431 cells, do not stimulate phosphorylation of EGF recep- 
tors at threonine-654. We conclude that this mode of activa- 
tion of Na+/H  ÷ exchange is independent of protein kinase 
C. The stimulation of events which are known to attenuate 
receptor activity by the binding of EGF to the EGF receptor 
implies that protein kinase C may be contributing to a feed- 
back mechanism in A431  cells. 
Materials and Methods 
Phorbol derivatives were purchased from LC  Services Corp.  (Woburn, 
MA) and stored as stock solutions in DMSO at -20°C. Mouse monoclonal 
antibody to the EGF receptor was purchased from Oncor (Gaithersburg, 
MD). [2-3H]Glycerol  and  [32P]orthophosphate  were from New England 
Nuclear (Boston, MA); [4,5-3H]leucine and [y-32p]ATP were from Amer- 
sham Corp. (Arlington Heights, IL). 1,2-Dioleoylglycerol and 1,2-dioleoyl- 
phosphatidic acid were purchased from Sigma Chemical Co.  (St. Louis, 
MO); formalin-fixed Staphylococcus aureus cells were from Bethesda Re- 
search Laboratories (Gaithersborg, MD); goat antibodies (IgG fraction) di- 
rected against mouse IgG (heavy and light chain specific) were purchased 
from CooperBiomedical Inc. (Malvern, PA), and Macherey-Nagel plastic- 
backed silica gel G sheets were from Brinkmann Instruments Co. (West- 
bury,  NY).  L-1-Tosylamido-2-phenylethyl  chloromethyl  ketone-treated 
trypsin was purchased from Worthington Biochemical Corp.  (Freehold, 
NJ). Sources of other reagents and all tissue culture methods have been de- 
scribed (34, 35). EGF was prepared by the method of Savage et al. (37). 
Assay of Diacylglycerol 
The measurement of DAG in lipid extracts from stimulated or unstimulated 
cells was performed by  incubating lipid and  [y-32p]ATP  with bacterial 
DAG kinase using a modification of the method of Kennedy et al.  (26). 
A431  cells were grown on 2-  x  1-cm glass slides, labeled for 24 h  in 
medium containing 1 IxCi/ml [3H]glycerol  and switched for the final 4 h to 
serum-free  Duibecco's  modified  Eagle's  medium  (DME)  containing  1 
0Ci/ml  [3H]glycorol.  Lipid extracts of the cells were obtained using a 
modification of the method of Bligh and Dyer (2). Each glass slide was ex- 
posed to EGF or control and placed in 5% TCA at 4°C to stop cellular me- 
tabolism. This step was found to be essential for rapid inactivation of the 
cellular enzymes that generate DAG. Direct solvent extraction of the cells 
gave higher basal levels of cellular DAG, which presumably resulted from 
inefficient enzyme inactivation. Each TCA-treated glass slide was placed in 
a  13  x  100 test tube containing 3 ml CHCI3/MeOH/0.1  N HCI (1:2:0.75). 
After 30 rain, the slide was removed and 1 ml CHCl3 plus 1 mi 0.1 N HCI 
was added and thoroughly mixed. The two phases were separated by cen- 
trifugation, the upper, aqueous phase was removed by aspiration, and the 
lower  phase  was  taken  to  dryness  under  N2.  The  lipid extracts  were 
resuspended in 200 ~tl CHCI3; duplicate 10-1xl aliquots were placed in 12- 
ml conical centrifuge tubes for the assay with DAG kinase and duplicate 50- 
I~1  aliquots  were analyzed for  [~H]. Phosphorylation of DAG  was per- 
formed in 25 Ixl of an aqueous solution containing 0.1% Cutscum detergent 
(vol/vol), 30 mM MgCI2,  105 mM NaCI, and 30 mM morpholinopropane 
sulfonic  acid  (MOPS)/NaOH,  pH  7.2,  with  1  mM  [y-32p]ATP  (800 
Ci/mol). The reaction was started by the addition of a membrane prepara- 
tion from Escherichia coli B containing DAG kinase (26). After 15 min at 
37°C, the reaction was terminated by the addition of 1 ml CHCI3/MeOH/ 
0.1 N HCI. After 10 rain at room temperature, two phases were obtained 
by the addition of 0.5 ml 0.1 N  HCI and 0.5 ml CHC13 containing 5  I.tg 
phosphatidic acid as a carrier. The upper phase was removed by aspiration 
and the lower phase was washed by the addition of 2 ml 0.1 N  HC1; the 
phases were separated by centrifugation and the upper phase was removed 
by aspiration. The lower, organic phase was taken to dryness under N2, 
dissolved in CHCI3 and spotted on silica gel G thin layer sheets. The sam- 
ples were resolved by a double one-dimensional thin layer chromatography 
system because of  the presence of detergent which caused tailing (26). Spots 
corresponding to [32p]phosphatidic  acid were revealed by autoradiography 
and counted by liquid scintillation spectroscopy. The principal modifica- 
tions of  the method of  Kennedy et al. (26) were (a) the use of TCA to rapidly 
stop metabolic activity; (b) the use of [3H]glycerol  incorporation into lipid 
to normalize for varying cell numbers growing on the glass chips and for 
recovery of cellular lipid by solvent extraction; (c) the omission of silicic 
acid column chromatography of lipid extracts which resulted in high vari- 
ability; (d) the decrease in total lipid being added to the DAG kinase assay 
which prevents nonspecific inhibition of the kinase and is compensated by 
a fourfold increase in specific activity of [y-a2p]ATP; and (e) the substitu- 
tion of plastic-hacked sheets for glass plates to simplify the quantification 
of [32p] in spots corresponding to phosphatidic acid on thin layer sheets. 
A separate measurement of [3H]lipid/106 cells was made from cells la- 
beled as above but trypsinized and counted with a Coulter counter. Lipid 
was extracted from duplicate 0.6-ml aliquots of the trypsinized cell solution 
by the addition of 2.4 ml CHCI3/MeOH/12 N HCI (2:1:0.005);  separation 
of the phases was achieved by the addition of I ml CHCI3 plus 1 ml 0.1 N 
HCI and centrifugation. The upper phase was removed by suction aspiration 
and the lower phase was evaporated under N2.  [3H] in lipid was measured 
by liquid scintillation spectroscopy. 
EGF Receptor Phosphorylation 
EGF  receptors  were  isolated  by  immunoprecipitation  from  dctergent- 
solubilized A431 cells. [32p]-labeled  tryptic peptides were separated by a 
modification of the method of Davis and Czech (12). A431 cells were plated 
in 60-mm dishes and grown until just confluent. 24 h before use, the cells 
were labeled in 2 ml with 1(30 ttCi/ml [31-I]leucine (to normalize the results 
to protein in the EGF receptor) in DME containing 10% serum; 3 h before 
use, the cells were washed twice and placed in 2 ml serum-free DME con- 
taining 10 I.tM 32pi (1 mCi/ml) and 1(30 IxCi/ml [3H]leacine.  After exposure 
to EGE PMA, or other treatments, coils were washed rapidly with PBS at 
37 °C and then solubilized with 1 ml of 1.5 % Triton X-100/1% sodium deoxy- 
cholate/0.1%  NaDOdSO4/0.5  M  NaCI/5 mM ethylene-diamine tetraacetic 
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fonyl fluoride/10 Bg leupeptin per ml/25 mM Hepes, pH 7.8 at 4°C (12). 
Cell lysates were centrifuged for 1 h at 100,000 g and immunoprecipitation 
was achieved by the addition of 20 gl anti-EGF receptor per ml of superna- 
tant with end-over-end mixing at 4"C for 2 h, followed by the addition of 
200 BI formalin-fixed S. aureus (coated with goat anti-mouse IgG) per ml 
cell lysate,  which was mixed for an additional 2  h  at 4"C.  The immu- 
noprecipitate was washed twice by centrifugation through PBS/0.5 % Triton 
X-100/I M NaCl/1 M sucrose, and receptors were dissociated by boiling 15 
rain in 60 I~1 5% NaDodSO4/20 mM dithiothreitol followed by centrifuga- 
tion. The receptors were reduced and alkylated by the addition of 30 BI 
0.4 M iodoacetamide/50 mM Tris, pH 8.6, for 15 min at room temperature 
followed by the addition of 25 gl 25 % 2-mercaptoethanol/25 % glycerol/ 
50% 50 mM Tris, pH 8.6, and incubation for 15 rain at 600C. The proteins 
were then  separated by  electrophoresis on a  7%  NaDodSOdpolyacryl- 
amide gel by the method of Laemmli (29). 
After electrophoresis, the [32p]-labeled  EGF receptors were located by 
autoradiography and the appropriate regions of the gel were washed with 
three changes of 85%  acetone/5% acetic acid/5% triethylamine/5% H20 
to remove the NaI)t~SO4.  The gel slices were digested at 37°C with 50 
gg/ml TPCK-treated trypsin in 3 ml of 50 mM NI-I4HCO3. After 14 h, a 
second addition of trypsin was made and the digestion was allowed to pro- 
ceed for a total of 24 h. The [32p]-labeled  phosphopeptides were lyophi- 
lized, dissolved in 300 BI of 1% trifluoroacetic acid, and 50 ltl was used 
to determine [31-1] content as a measure of EGF receptor protein. The pep- 
tides in 250 B1 were resolved by reverse-phase HPLC using a Waters gBon- 
dapak C~s column equilibrated with 0.1% trifluoroacetic acid. The column 
was washed for 5 rain and then the phosphopeptides  were eluted by a linear 
gradient of acetonitrile (0-55%) over 55 rain. The flow rate was 1 ml/min 
and fractions were collected every 1 rain. The [32p]phosphopeptides were 
detected by measuring Cerenkov radiation. Phosphoamino acid analysis was 
performed by the method of Hunter and Sefton (21). 
Preparation of  Synthetic Phosphopeptides 
The synthetic pentapeptide, Lys-Arg-Thr-Leu-Arg, used as a reference, was 
kindly prepared by Mr. Joseph Leykam (Washington University, St. Louis, 
MO) and the sequence was confirmed  by automated Edman degradation. 
The peptide was phosphorylated using the catalytic subunit of the cAMP- 
dependent protein kinase (a gift from Dr. Linda Pike, Washington Univer- 
sity,  St. Louis, MO) in a mixture containing 200 BM [y-3:p]ATP,  10 mM 
MgCI2,  20 mM 2-mercaptoethanol, and 40 mM Tris, pH 6.8. After incu- 
bation for 2 h at 37°C, bovine serum albumin was added as a protein carder 
and protein was precipitated by the addition of concentrated TCA to a final 
concentration of 5 %  (wt/vol).  After centrifugation, the supernatant was 
spotted on 2- x  2-cm squares of phosphocellulose paper and after drying, 
was washed with four changes of 75 mM phosphoric acid. The phosphopep- 
tide was finally eluted with 0.5 M ammonium formate, pH 10, and lyophi- 
lized before purification by reverse-phase HPLC. 
Results 
EGF-stimulated DAG Generation 
Sawyer and Cohen (38) reported that EGF-stimulated phos- 
phatidylinositol (PI) turnover in A431 cells, which they mea- 
sured as  [32P]phosphate  or [3H]inositol incorporation into 
PI. They suggested that protein kinase C could be activated 
in EGF-stimulated cells by inferring that increased DAG lev- 
els are a consequence of  the observed increase in PI turnover. 
DAG is  very rapidly metabolized to phosphatidic acid  in 
most cells, therefore only direct measurements of the con- 
centrations of DAG are likely to be relevant to the activity 
of protein kinase C.  We have modified the method of Ken- 
nerly et al. (26) to be able to rapidly measure the levels of 
DAG in cells.  One of the most important modifications is 
rapid inactivation of cellular metabolism before lipid extrac- 
tion.  For example, direct extraction of cells without prior 
treatment with TCA resulted in a 40% increase in DAG and 
solubilization of ceils in NaDodSO4 at 4°C before extrac- 
tion resulted in DAG levels which were 2.7-fold greater than 
DAG levels from acid-treated cells. 
In Table I we show the amounts of DAG in cells treated 
with EGE A modest increase is observed 2 rain after addi- 
tion of EGF and this increase remained elevated after 10 min. 
The absolute values of DAG are, however, dependent on the 
prior treatment of cells; for example, length of exposure of 
cells to 1% serum. In no case did we observe EGF-induced 
increases in DAG levels greater than 45 %. The modest in- 
creases in DAG levels makes it extremely difficult to interpret 
these observations in terms of  protein kinase C activity, since 
the cellular location of the DAG is not known. Note that the 
increase in DAG concentration is much less than what would 
be inferred from a sixfold increase in the rate of PI turnover 
(38). 
Identification of  the Phosphopeptides 
Containing Threonine-654 
Davis and Czech (12) reported that tryptic phosphopeptides 
derived from the EGF receptor could be resolved by reverse- 
phase  HPLC  analysis  and  that  two  [32p]-labeled  phos- 
phopeptides  containing  threonine-654  and  eluting  at  low 
acetonitrile  concentrations  could  be  identified  in  tryptic 
digests of the EGF receptor derived from PMA-treated cells. 
They designated the two phosphopeptides, "1" and "2; and 
identified "2" as the pentapeptide, Lys-Arg-Thr(P)-Leu-Arg. 
They reported that trypsin digestion slowly converted "2" to 
the tetrapeptide Arg-Thr(P)-Leu-Arg, which was designated 
as peptide "1"; the numbers represent the order of their elu- 
tion  by  reverse-phase  HPLC.  The tryptic maps  of EGF 
receptors derived from PMA-treated and  control cells  is 
shown in Fig. 1 A. In every chromatogram, a peak of varying 
size is  observed at 4  rain,  which  represents  free  [32p]Pi. 
The next two peaks,  which elute at 24 and 28 rain,  cor- 
respond to the phosphopeptides "1" and "2" of Davis and 
Czech (12). A third peak elutes at 30 rain and is seen in con- 
trol cells as well as PMA-treated cells. The only other char- 
acteristic feature of Fig.  1 A is a large peak eluting at ,,o46 
min which appears to represent stable site(s) ofphosphoryla- 
tion because [32p] in control cells is predominantly found in 
this  phosphopeptide.  Fig.  1 B  demonstrates  that  the two 
peaks,  "1" and "2; of Davis and Czech (12) are present in 
tryptic  maps  of the  EGF  receptor  obtained  from  EGF- 
stimulated cells as well as PMA-treated cells. Phosphoamino 
acid analysis of peaks 1, 2, and 3 from EGF-stimulated cells 
(Fig.  1 B) demonstrates that peaks  1 and 2  contain phos- 
phothreonine while peak 3 contains phosphoserine (see Fig. 
3). Phosphoamino acid analysis of  the phosphopeptides 1, 2, 
Table L Effect of  EGF Addition on the Concentration 
of  DAG in A431 Cells 
Time after EGF 
addition  DAG  Normalized value 
rain  pmol/lO  6 cells 
0  1,982  (+  149)*  1.00 
2  2,523  (5=  173)  1.27 
10  2,584  (:i:  187)  1.30 
A431 cells were grown as described in Materials and Methods; after exposure 
of cells to EGF (100 ng/ml), lipids were extracted from cells and DAG concen- 
tration  was determined. 
*SEM, n  =  3. 
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Figure 1.  Phosphopeptide maps of the EGF receptor from A431 
cells. (A) EGF receptors derived from control cells (solid line) and 
cells treated with 10 nM PMA for 15 min (dashed line). (B) EGF 
receptors derived from control cells (solid line) and cells exposed 
to 200 ng/rnl EGF for 15 min (dashed line). Trypsin digestion and 
HPLC were as described in Materials and Methods. The peaks la- 
beled 1, 2, and 3 in B correspond to samples in Fig. 3. 
and 3  from PMA-treated cells was  identical to the results 
found in Fig. 2 (data not shown). To confirm the assignment 
of Lys-Arg-Thr(P)-Leu-Arg  as peptide 2, we synthesized this 
pentapeptide and phosphorylated it using [y-32p]ATP as de- 
scribed.  After trypsinization of the synthetic phosphopen- 
tapeptide for 24 h with 50 l~g/ml TPCK-treated trypsin, the 
two phosphopeptide products were chromatographed by re- 
verse-phase HPLC and found to co-elute with peaks 1 and 
2 (Fig.  1 B) (data not shown). In all calculations, the sum 
of [32p] in peaks 1 and 2 is used to measure the total phos- 
phate incorporation into threonine-654 of the EGF receptor. 
In Fig.  1 B,  a  sharp peak eluted at 35 min.  This phos- 
phopeptide contains phosphotyrosine (data not shown) and 
presumably represents a single site of autophosphorylation 
of the receptor after treatment with  EGE  The [32p]p~ in- 
corporated into this phosphopeptide is used as a reference in 
calculations  designed  to  estimate  the  relative amount  of 
threonine-654 phosphorylation. 
Effect of  EGF on the Phosphorylation of Threonine-654 
Fig.  1 b  is a peptide map of the EGF receptor from 32Pi- 
labeled cells showing peaks  1 and 2 which represent Arg- 
Thr(P)-Leu-Arg and Lys-Arg-Thr(P)-Leu-Arg, respectively. 
The two phosphopeptides, known to be produced by PMA 
treatment (12) are also generated by EGF addition to A431 
cells (Fig.  1 b). The time course of phosphopeptide forma- 
tion after the addition of EGF is shown in Fig. 3. The phos- 
phorylation of threonine-654 was detected as early as 1 rain 
after EGF addition and maximal phosphate incorporation 
seemed to occur 5 rain after EGF addition. EGF stimulates 
substantial phosphorylation of  tyrosine in EGF receptors and 
one phosphotyrosine-containing tryptic peptide is found to 
elute at 30% acetonitrile (fraction 35) during reverse-phase 
HPLC. The identity of phosphotyrosine in this peptide was 
confirmed by phosphoamino acid analysis (data not shown). 
To estimate the extent of threonine-654 phosphorylation in 
EGF-stimulated cells, the fraction of [32p] incorporated into 
peaks  1 and  2  relative to  [32p]Pi  in the phosphotyrosine- 
containing peptide at fraction 35 was calculated. Using this 
method, in two experiments [32p]Pi incorporation into thre- 
onine-654 was 43 and 53 % of [32p]Pi incorporation due to 
autophosphorylation (Table II).  In  these  experiments  we 
used 200 ng/ml of EGF which gave a maximal biological re- 
sponse in these cells (22, 35). The phosphotyrosine peptide 
eluted at fraction 35 appears to represent the major phos- 
photyrosine autophosphorylation site in the EGF receptor, 
at tyrosine 1173 (14).  If we assume that 200 ng/ml  EGF- 
stimulated autophosphorylation in essentially 100%  of the 
EGF receptors then the values in Table II would allow us to 
estimate the percentage of receptors which have been phos- 
phorylated at threonine-654. Our conclusion is that 40-50% 
of the EGF receptors may be modified by the action of EGF- 
stimulated protein kinase C. 
Phosphorylation of  EG  F Receptors by Exposure to 
Hypertonic Medium 
Exposure of A431 cells to medium of increased osmolarity 
leads to activation of Na+/H  + exchange and to an increase in 
intracellular pH which displays similar kinetics to that ob- 
served upon addition of mitogens to the cells (6).  Na+/H  + 
exchange also appears to be activated during the regulatory 
volume increase response in certain epithelial cells (16) and 
nucleated erythrocytes (5,  28).  Whereas Na+/H  + exchange 
acts to restore epithelial cell and erythrocyte  volume after ex- 
posure  to  hypertonic  solutions,  A431  cell  volume is  not 
significantly affected by Na+/H  + exchange activity (6). The 
role of protein kinase C is poorly understood during volume 
regulation in various cells or osmotic perturbation in A431 
cells, but PMA has been observed to exert effects similar to 
osmotic perturbation (19) which has led to speculation that 
the activity of protein kinase C mediates volume regulation 
in certain cells. Fig. 4 shows the HPLC profile of EGF recep- 
tor tryptic phosphopeptides from A431 cells exposed for 30 
min to medium made 200 mM hypertonic by the addition of 
2 M sucrose (200 I~l into 2 ml isotonic medium). There was 
no  difference from control  at  the  positions  of the  phos- 
phopeptides  1  and  2,  which  correspond to  [32P]-labeled 
threonine-654. This implies that protein kinase C is not acti- 
vated by exposure to hypertonic medium, a treatment which 
results in potent stimulation of Na+/H  + exchange. An alter- 
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analysis of  peptides from EGF 
receptor.  The  peptides  were 
obtained from EGF receptors, 
derived  from  cells  to  which 
EGF was added for 15 rain and 
are identified by numbers as in 
Fig.  1 B.  A  shows  ninhydrin 
staining of samples and indi- 
cates  the  positions  of phos- 
phoamino acid standards after 
electrophoresis  on  thin-layer 
cellulose sheets by the method 
of Hunter and Sefton (21). B 
shows  the  autoradiogram  of 
the  chromatograph  in A  (for 
details  see  Materials  and 
Methods). 
native, albeit unlikely,  explanation could be that protein ki- 
nase C  is activated, but that the EGF receptor is not a  sub- 
strate after osmotic perturbation.  Fig. 4  also shows that 100 
nM 4a-PMA has no effect on [32P]Pi incorporation  into the 
EGF receptor, therefore, the PMA effects are stereospecific 
and are consistent with the known specificity of protein ki- 
nase C  activation by phorbol  diesters  (7). 
Discussion 
The role of protein kinase C  as a  mediator of the response 
of cells to mitogens has been the subject of considerable de- 
bate. Since phorbol diesters are mitogenic for some cells and 
a number of mitogens activate PI turnover it seemed reason- 
able to assume that protein kinase C might be responsible for 
the  mitogenic  response.  As  described  in  the  introduction, 
detailed studies of the EGF receptor suggested that it is inac- 
tivated by phosphorylation at threonine-654,  which is cata- 
lyzed by protein kinase C.  Previously,  we reported that ex- 
posure  of  cells  to  low  concentrations  of  PMA  causes 
attenuation  of Na+/H  + exchange  activation  by EGF  or  se- 
rum in .4.431  cells  (44)  and  PDGF  or serum in NR6 cells 
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Figure 3. Time course of phosphory- 
lation of the  EGF receptor at thre- 
onine-654.  EGF  receptors  derived 
from  control  cells  (solid  line)  and 
cells treated with 200 ng/ml EGF for 
1 min (dashed line),  5  min (dotted 
line),  or 15 min (dashed and dotted 
line).  Trypsin digestion and  HPLC 
analysis  is  described  in  Materials 
and Methods. The peaks labeled 1, 2, 
and 3  correspond to the samples in 
Fig.  3. 
Whitely and Glaser Phosphorylation at Threonine-654 of the EGF Receptor  1359 Table II. Extent of  Phosphorylation  of  EGF Receptors 
at Threonine-654 
Time  Ratio 
Exp.  1 
Exp.  2 
rain 
1.0  0.38 
5.0  0.50 
15.0  0.53 
1.0  0.23 
5.0  0.42 
15.0  0.43 
Relative phosphorylation  of  threonine-654 as a result of exposure  of A431 cells 
to EGF (200 ng/ml) for varying lengths of time was determined by measuring 
the ratio of [32p] in threonine-654-eontaining peptides to the [32p] content of 
a tyrosine-containing peptide which eluted at 35  min (see Materials and 
Methods). Note that the ratio of phosphorylation in these two peptides in- 
creases between 1 and 5 rain of exposure to EGF, and represents increased 
phosphorylation of threonine-654. 
(45).  The mechanism of this  inhibition  is not known with 
certainty,  but could be fully explained by the inhibition  of 
mitogen receptor tyrosine kinase activity.  Phorbol  diesters 
have also been shown to decrease phosphoinositide hydroly- 
sis  and  Ca  2÷ mobilization  in thrombin-stimulated  platelets 
(43).  In Swiss  3T3 cells,  the mitogens  serum,  PDGF,  and 
fibroblast  growth  factor  have  been  shown  to  stimulate  a 
rapid,  transient rise in [Ca  2÷] which is inhibitable by a  30- 
rain pretreatment with PMA (31).  Therefore, the ability of 
PMA  to block mitogenic  stimulation  of Na+/H  ÷ exchange 
might also be attributable to inhibition of Ca  2+ mobilization 
or PI turnover. 
Other investigators have also shown that the function of a 
variety of cell surface receptors  for hormones or mitogens 
can be "inactivated" by phorbol diesters which activate pro- 
tein kinase C (25, 40, 42), suggesting that in all of these sys- 
tems the PI cycle serves as part of a feedback loop to modu- 
late  the  activity  of these  receptors.  Heterologous  ligands 
such as PDGF (3, 46),  vasopressin (36),  and bombesin (4) 
have been shown to cause decreases in EGF receptor affinity 
in 3T3 cells in a manner similar to phorbol diesters.  All of 
these peptide ligands have, in common, the ability to stimu- 
late phosphoinositide hydrolysis and cause the liberation of 
DAG.  Therefore,  the  effects  of  PDGF,  vasopressin,  and 
bombesin on EGF receptor affinity in 3T3 cells are likely to 
be mediated by protein kinase C activity and the subsequent 
phosphorylation of threonine-654 of the EGF receptor. The 
modulation of the EGF receptor by heterologous ligands, an 
example of what might be termed "cross talk" between mito- 
gen receptors, is an important example of the way in which 
protein kinase C may be functioning during mitogenic stimu- 
lation of quiescent cells.  Since EGF has also been reported 
to cause stimulation of phosphoinositide turnover, the poten- 
tial for homologous regulation of the EGF receptor is appar- 
ent.  Evidence  for this  type of regulation  must begin with 
measurements designed to determine whether protein kinase 
C  activity increases after addition of EGF to intact cells. 
Measurements  of intracellular  Ca  2+ or  DAG  levels as  a 
way of assessing changes in protein kinase C levels are usu- 
ally  ambiguous  since  the effective concentrations  of these 
ligands  available to C-kinase  are unknown.  The measure- 
ment of cytoplasmic Ca  2÷ after addition of mitogens by the 
use of aequorin, which may be the most reliable method cur- 
rently available, suggests that increases in Ca  2÷ may be ex- 
tremely transient (31). As documented here, the determina- 
tion of DAG levels (Table I) when carried out carefully only 
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Figure  4.  Effect  of  hyper- 
tonicity on phosphorylation of 
EGF receptors in A431 cells. 
EGF  receptors  derived  from 
control cells  (solid line)  and 
cells treated with 100 nM 4a- 
PMA (dotted line) or cells ex- 
posed to hypertonic medium 
(dashed  line).  Trypsinization 
and  HPLC  analysis  is  de- 
scribed in Materials and Meth- 
ods. The elution positions of 
phosphopeptides  containing 
threonine-654  are  indicated 
by the numbers 1 and 2. The 
data indicate that this residue 
is  not  phosphorylated  under 
hypertonic conditions or after 
addition of a phorbol diester 
which does not activate pro- 
tein kinase C. 
The Journal of Cell Biology, Volume 103, 1986  1360 indicated a  small but possibly significant change in DAG 
concentration after addition of EGF to A431 cells. However, 
by themselves, these data cannot be used to indicate that pro- 
tein kinase C is activated after addition of  EGF to A431 cells. 
Davis and Czech (12) have provided a direct method for as- 
saying the activity of protein kinase C in cells with high lev- 
els of EGF receptor by measuring phosphorylation of the 
EGF receptor at threonine-654. We have introduced some 
minor modifications of this method and have controlled for 
receptor recovery by the use of [3H]leucine to metabolically 
label the EGF receptor. 
Our observations suggest that protein kinase C is rapidly 
activated after addition of EGF to ceils and remains active 
for substantial periods of time (at least 15 min) after addition 
of EGF to cells. The existence of the proposed feedback loop 
by which activation of  protein kinase C might "inactivate" the 
EGF receptor is thus confirmed. However, the magnitude of 
the effect is hard to estimate. If, as assumed above, we use 
as a reference  point the phosphorylation of a tyrosine residue 
in the receptor, we can estimate that 40-50%  of the EGF 
receptor molecules are phosphorylated at threonine-654, a 
rather substantial number. We also observed that the degree 
of phosphorylation of threonine-654 after addition of EGF 
to A431  cells is comparable to that observed after addition 
of PMA (see Fig. 1, A and B), again suggesting that the acti- 
vation of  protein kinase C after addition of  EGF to A431 cells 
is biologically significant. While the data clearly support the 
presence of such a feedback loop in A431 cells, its presence 
in other cell types remains to be determined. The high level 
of EGF receptors in A431 cells makes the type of measure- 
ment we have described easier, but also may magnify the re- 
sponse. 
Recent studies using synthetic peptide substrates (15) indi- 
cate that phosphorylation of the isolated EGF receptor by 
protein kinase  C  in  vitro may  only reduce the  tyrosine- 
protein kinase activity of the receptor at saturating EGF con- 
centrations by only 20 %. However, we observed that a 60- 
min treatment with  10  -s M  PMA  followed by addition of 
EGF for 5 min caused a 70% decrease in EGF-stimulated 
[32p] incorporation into a phosphopeptide which is believed 
to contain a  single tyrosine autophosphorylation site.  This 
inhibition of tyrosine kinase activity by phorbol diesters in 
vivo which has been reported by others previously (17) is 
significantly greater than that observed by Downward et al. 
(15) in vitro, thus the solubilized system is somehow not rep- 
resentative of the interactions of protein kinase C  and the 
EGF receptor in vivo. To accurately estimate the modulation 
of  the EGF receptor tyrosine kinase activity by EGF-induced 
protein kinase C activity in the absence of other metabolic 
events, it would be necessary to measure autophosphoryla- 
tion in the presence or absence of protein kinase C in intact 
cells. Unfortunately, the compounds which have been shown 
to inhibit the activity of protein kinase C  in vitro are too 
nonspecific or are ineffective in vivo. Furthermore, the tech- 
nique of down-regulating protein kinase C  by chronic ex- 
posure of cells to high concentrations of phorbol diesters (11) 
has  recently been  shown  to  cause  a  change  in  substrate 
specificity rather than a decrease in total activity of the en- 
zyme in some cell types (10). A 24-h exposure to 400 nM 
PMA does not significantly decrease the activity of protein 
kinase C in A431 cells (Whiteley, B., unpublished observa- 
tions). 
Continuous recording of  intracellular pH after mitogen ad- 
dition to A431 cells has revealed that EGF or serum induces 
an amiloride-sensitive pHi increase after a lag period of ,,02 
min (35). Intracellular pH increases to a new steady state, 
but then returns to the initial prestimulatory level 30-60 min 
after mitogen addition (Whiteley, B., unpublished observa- 
tions).  This transient nature of intracellular alkalinization 
might also be due to negative modulation of the stimulation 
by the EGF receptor of Na÷/H  + exchange, which could be 
mediated by protein kinase C. 
Received for publication 5  May 1986,  and in revised form 18 June 1986. 
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